Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial.
Privé BM, Janssen MJR, van Oort IM, Muselaers CHJ, Jonker MA, de Groot M, Mehra N, Verzijlbergen JF, Scheenen TWJ, Zámecnik P, Barentsz JO, Gotthardt M, Noordzij W, Vogel WV, Bergman AM, van der Poel HG, Vis AN, Oprea-Lager DE, Gerritsen WR, Witjes JA, Nagarajah J. Privé BM, et al. BMC Cancer. 2020 Sep 14;20(1):884. doi: 10.1186/s12885-020-07386-z. BMC Cancer. 2020. PMID: 32928177 Free PMC article. Clinical Trial.
Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation.
Unterrainer M, Deroose CM, Herrmann K, Moehler M, Blomqvist L, Cannella R, Caramella C, Caruso D, Chouhan MD, Denecke T, De la Pinta C, De Geus-Oei LF, Dulskas A, Eisenblätter M, Foley KG, Gourtsoyianni S, Lecouvet FE, Lopci E, Maas M, Obmann MM, Oprea-Lager DE, Verhoeff JJC, Santiago I, Terraz S, D'Anastasi M, Regge D, Laghi A, Beets-Tan RGH, Heinemann V, Lordick F, Smyth EC, Ricke J, Kunz WG; European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group. Electronic address: https://twitter.com/@EORTC; European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Group; European Society of Oncologic Imaging (ESOI) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR). Unterrainer M, et al. Eur J Cancer. 2022 Nov;176:193-206. doi: 10.1016/j.ejca.2022.09.012. Epub 2022 Sep 28. Eur J Cancer. 2022. PMID: 36274570 Free article.
A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial.
van Dodewaard-de Jong JM, de Klerk JMH, Bloemendal HJ, Oprea-Lager DE, Hoekstra OS, van den Berg HP, Los M, Beeker A, Jonker MA, O'Sullivan JM, Verheul HMW, van den Eertwegh AJM. van Dodewaard-de Jong JM, et al. Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1319-1327. doi: 10.1007/s00259-017-3673-9. Epub 2017 Apr 18. Eur J Nucl Med Mol Imaging. 2017. PMID: 28421240 Clinical Trial.
Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT.
Bouman-Wammes EW, van Dodewaard-De Jong JM, Dahele M, Cysouw MCF, Hoekstra OS, van Moorselaar RJA, Piet MAH, Verberne HJ, Bins AD, Verheul HMW, Slotman BJ, Oprea-Lager DE, Van den Eertwegh AJM. Bouman-Wammes EW, et al. Clin Genitourin Cancer. 2017 Oct;15(5):e773-e782. doi: 10.1016/j.clgc.2017.03.009. Epub 2017 Mar 29. Clin Genitourin Cancer. 2017. PMID: 28462855
Prognostic Value of [18F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.
Cysouw M, Bouman-Wammes E, Hoekstra O, van den Eertwegh A, Piet M, van Moorselaar J, Boellaard R, Dahele M, Oprea-Lager D. Cysouw M, et al. Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):406-410. doi: 10.1016/j.ijrobp.2018.02.005. Epub 2018 Feb 13. Int J Radiat Oncol Biol Phys. 2018. PMID: 29559285
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group.
Lecouvet FE, Oprea-Lager DE, Liu Y, Ost P, Bidaut L, Collette L, Deroose CM, Goffin K, Herrmann K, Hoekstra OS, Kramer G, Lievens Y, Lopci E, Pasquier D, Petersen LJ, Talbot JN, Zacho H, Tombal B, deSouza NM. Lecouvet FE, et al. Lancet Oncol. 2018 Oct;19(10):e534-e545. doi: 10.1016/S1470-2045(18)30571-0. Epub 2018 Oct 1. Lancet Oncol. 2018. PMID: 30303127 Review.
Healthy Tissue Uptake of 68Ga-Prostate-Specific Membrane Antigen, 18F-DCFPyL, 18F-Fluoromethylcholine, and 18F-Dihydrotestosterone.
Jansen BHE, Kramer GM, Cysouw MCF, Yaqub MM, de Keizer B, Lavalaye J, Booij J, Vargas HA, Morris MJ, Vis AN, van Moorselaar RJA, Hoekstra OS, Boellaard R, Oprea-Lager DE. Jansen BHE, et al. J Nucl Med. 2019 Aug;60(8):1111-1117. doi: 10.2967/jnumed.118.222505. Epub 2019 Jan 10. J Nucl Med. 2019. PMID: 30630941 Free PMC article.
Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer.
Jansen BHE, Yaqub M, Voortman J, Cysouw MCF, Windhorst AD, Schuit RC, Kramer GM, van den Eertwegh AJM, Schwarte LA, Hendrikse NH, Vis AN, van Moorselaar RJA, Hoekstra OS, Boellaard R, Oprea-Lager DE. Jansen BHE, et al. J Nucl Med. 2019 Dec;60(12):1730-1735. doi: 10.2967/jnumed.119.227520. Epub 2019 Apr 18. J Nucl Med. 2019. PMID: 31000583 Free article.
127 results